FDA Inspection
Colgate-Palmolive CompanyColgate-Palmolive Company – FDA Inspection, May 30, 2019
Record Details
This FDA Inspection record concerns Colgate-Palmolive Company, with an inspection on May 30, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · daeb6a41-c621-4a28-951e-14fba4d20c33
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1091323
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- FDCA 760(b)(1)No label copy submitted with AE report (non-Rx drug)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Colgate-Palmolive Company
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 20, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 16, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 26, 2024 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| October 31, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 22, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Colgate-Palmolive Company
- FDA Inspection 1280473 - 2025-08-20
- FDA Inspection 1233220 - 2024-02-16
- FDA Inspection 1228569 - 2024-01-26
- FDA Inspection 1041194 - 2017-10-31
- FDA Inspection 833599 - 2013-05-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.